HAVCR2 and neoplasm: This is a result of TIM3-mediated immunosuppression operating in micrometastasis and further supported by tumor-intrinsic stem cell properties, as suggested by the moderate increase of Tim3+-lineage cells upon induction in immunodeficient mice, and the TIC ability of TIM3+ cells in LDA in vivo assays.